Polyamine-Conjugated Nitroxides Are Efficacious Inhibitors of Oxidative Reactions Catalyzed by Endothelial-Localized Myeloperoxidase
- 4 June 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 34 (6) , 1681-1692
Abstract
The heme enzyme myeloperoxidase (MPO) is a key mediator of endothelial dysfunction and a therapeutic target in cardiovascular disease. During inflammation, MPO released by circulating leukocytes is internalized by endothelial cells and transcytosed into the subendothelial extracellular matrix of diseased vessels. At this site, MPO mediates endothelial dysfunction by catalytically consuming nitric oxide (NO) and producing reactive oxidants, hypochlorous acid (HOCl) and the nitrogen dioxide radical (•NO2). Accordingly, there is interest in developing MPO inhibitors that effectively target endothelial-localized MPO. Here we studied a series of piperidine nitroxides conjugated to polyamine moieties as novel endothelial-targeted MPO inhibitors. Electron paramagnetic resonance analysis of cell lysates showed that polyamine conjugated nitroxides were efficiently internalized into endothelial cells in a heparan sulfate dependent manner. Nitroxides effectively inhibited the consumption of MPO’s substrate hydrogen peroxide (H2O2) and formation of HOCl catalyzed by endothelial-localized MPO, with their efficacy dependent on both nitroxide and conjugated-polyamine structure. Nitroxides also differentially inhibited protein nitration catalyzed by both purified and endothelial-localized MPO, which was dependent on •NO2 scavenging rather than MPO inhibition. Finally, nitroxides uniformly inhibited the catalytic consumption of NO by MPO in human plasma. These studies show for the first time that nitroxides effectively inhibit local oxidative reactions catalyzed by endothelial-localized MPO. Novel polyamine-conjugated nitroxides, ethylenediamine-TEMPO and putrescine-TEMPO, emerged as efficacious nitroxides uniquely exhibiting high endothelial cell uptake and efficient inhibition of MPO-catalyzed HOCl production, protein nitration, and NO oxidation. Polyamine-conjugated nitroxides represent a versatile class of antioxidant drugs capable of targeting endothelial-localized MPO during vascular inflammation.Keywords
Funding Information
- Diabetes Australia Research Trust
- National Health and Medical Research Council (APP1058508, APP1125392)
- University of New South Wales
This publication has 40 references indexed in Scilit:
- Myeloperoxidase: A versatile mediator of endothelial dysfunction and therapeutic target during cardiovascular diseasePharmacology & Therapeutics, 2021
- Myeloperoxidase: A Leukocyte-Derived Protagonist of Inflammation and Cardiovascular DiseaseAntioxidants & Redox Signaling, 2013
- Plasma myeloperoxidase is inversely associated with endothelium-dependent vasodilation in elderly subjects with abnormal glucose metabolismMetabolism, 2010
- Redox Control of Endothelial Function and Dysfunction: Molecular Mechanisms and Therapeutic OpportunitiesAntioxidants & Redox Signaling, 2008
- Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusionFree Radical Biology and Medicine, 2004
- Serum Myeloperoxidase Levels Independently Predict Endothelial Dysfunction in HumansCirculation, 2004
- Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitrationJournal of Clinical Investigation, 2001
- Macrophage Myeloperoxidase Regulation by Granulocyte Macrophage Colony-Stimulating Factor in Human Atherosclerosis and Implications in Acute Coronary SyndromesThe American Journal of Pathology, 2001
- Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesionsEuropean Journal of Biochemistry, 2000
- Presence of hypochlorite-modified proteins in human atherosclerotic lesions.Journal of Clinical Investigation, 1996